[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100646777":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":24,"centralContacts":28,"locations":34,"responsibleParty":49,"collaborators":24,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":24,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":60,"maxAge":61,"enrollmentInfo":62,"targetDuration":24,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":73,"overallStatus":37,"whyStopped":24,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Ankara City Hospital Bilkent","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Ultrasound-Guided Pulsed Radiofrequency Treatment","EXPERIMENTAL","Participants in this group will receive ultrasound-guided pulsed radiofrequency treatment at baseline. Clinical follow-up assessments will be performed at 3 weeks, 6 weeks, and 12 weeks. All participants will also receive a home-based plantar fascia stretching exercise program.",[13],"Procedure: Ultrasound-Guided Pulsed Radiofrequency Treatment",{"label":15,"type":16,"description":17,"interventionNames":18},"Ultrasound-Guided 5% Dextrose Injection","ACTIVE_COMPARATOR","Ultrasound-guided pulsed radiofrequency treatment will be applied for chronic plantar fasciitis. Participants will be monitored for at least 30 minutes after the procedure for possible adverse events or complications.",[19],"Procedure: Ultrasound-Guided 5% Dextrose Injection",[21,25],{"type":22,"name":9,"description":17,"armGroupLabels":23,"otherNames":24},"PROCEDURE",[9],null,{"type":22,"name":15,"description":26,"armGroupLabels":27,"otherNames":24},"Ultrasound-guided 5% dextrose injection will be applied around the medial calcaneal insertion of the plantar fascia using the peppering technique, with 0.1-0.2 mL administered at each entry point. The treatment will consist of three sessions performed at 3-week intervals.",[15],[29],{"name":30,"role":31,"phone":32,"phoneExt":24,"email":33},"Esra Ülgen Kıratlıoğlu, MD","CONTACT","+905079614194","esraulgen@gmail.com",[35],{"facility":36,"status":37,"city":38,"state":24,"zip":24,"country":39,"countryCode":24,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Ankara Bilkent City Hospital, Physical Medicine and Rehabilitation Hospital","RECRUITING","Ankara","Turkey (Türkiye)",{"type":41,"coordinates":42},"Point",[43,44],32.85427,39.91987,{"lat":44,"lon":43},[47],{"name":48,"role":31,"phone":32,"phoneExt":24,"email":33},"Esra Ülgen Kıratlıoğlu",{"type":50,"investigatorFullName":48,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"PRINCIPAL_INVESTIGATOR","MD","100646777","pulsed-radiofrequency-versus-5-dextrose-injection-in-chronic-plantar-fasciitis-100646777",false,"NCT07688876","Pulsed Radiofrequency Versus 5% Dextrose Injection in Chronic Plantar Fasciitis","Comparison of Ultrasound-Guided Pulsed Radiofrequency and 5% Dextrose Injection in Patients With Chronic Plantar Fasciitis: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Diagnosis of chronic plantar fasciitis based on medical history and physical examination\n* Heel pain resistant to conservative treatment for at least 12 weeks\n* Age between 18 and 70 years\n* Willingness to participate in the study and provide written informed consent\n\nExclusion Criteria:\n\n* Congenital or acquired disease that may impair or prevent foot function, such as rheumatoid arthritis, hemiplegia, congenital foot deformity, traumatic foot or leg amputation, or fracture sequelae\n* Local infection or skin disease at the treatment site\n* Bleeding disorder or use of anticoagulant medication within the last week\n* Disease causing mental dysfunction, such as uncontrolled Parkinson disease or Alzheimer disease\n* Previous surgery for plantar fasciitis\n* Refusal to participate in the study or inability to provide informed consent\n* Failure to attend follow-up visits after treatment\n* Request to withdraw from the study\n* Pregnancy or suspected pregnancy\n* Presence of a cardiac pacemaker\n* History of epilepsy\n* Active or previous malignancy\n* Rheumatologic disease","ALL","18 Years","70 Years",{"count":63,"type":64},50,"ESTIMATED","INTERVENTIONAL",[67],"NA","This prospective, two-center, randomized controlled clinical trial aims to compare the effectiveness of ultrasound-guided pulsed radiofrequency and 5% dextrose injection in patients with chronic plantar fasciitis. Eligible participants will be randomized into two parallel groups. One group will receive ultrasound-guided pulsed radiofrequency treatment, and the other group will receive ultrasound-guided 5% dextrose injection using the peppering technique. All participants will receive a home-based plantar fascia stretching exercise program. Outcomes will be assessed at baseline, 3 weeks, 6 weeks, and 12 weeks after treatment. The primary outcome will be pain intensity measured by the Numeric Rating Scale. Secondary outcomes will include foot function, activity-related pain, ankle-hindfoot function, and health-related quality of life.",[70,71,72],"Chronic Plantar Fasciitis","Chronic Heel Pain","Foot Pain",[74,75,76,77,78,79,80,81,82,83,84],"Pulsed radiofrequency","Radiofrequency treatment","Dextrose injection","Prolotherapy","Ultrasound-guided injection","Plantar fascia","Chronic heel pain","Numeric Rating Scale","Foot Function Index","AOFAS score","Nottingham Health Profile","2026-06-30",{"date":87,"type":88},"2026-07-07","ACTUAL",{"date":90,"type":88},"2026-01-01",{"date":92,"type":64},"2027-01-01",{"name":5,"class":6},1]